Sponsor pipeline

Harbin Medical University clinical trial pipeline

Get alerts when Harbin Medical University's trials change

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

4 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 3 with minor changes only.

Notable

Improvement of Myocardial Microcirculation After Acute Anterior Myocardial Infarction

Primary completion pushed from Dec 31, 2024 to Dec 31, 2026

Also in this update: Study completion pushed from Jun 30, 2025 to Dec 31, 2026

Harbin Medical UniversityNot applicable NCT06154395 Registry history of NCT06154395 on ClinicalTrials.gov (opens the registry)

Oct 16, 2026

Show 3 trials with minor changes only

Minor

Trastuzumab Rezetecan and Adebrelimab as Neoadjuvant Therapy for HER2-Positive Muscle-Invasive Bladder Cancer

Trial status changed: Not Yet Recruiting → Active, Not Recruiting

Harbin Medical UniversityPhase 2 NCT07624201 Registry history of NCT07624201 on ClinicalTrials.gov (opens the registry)

Oct 19, 2026
Minor

Application of Remimazolam Combined With Esketamine in Painless Gastroscopy and Colonoscopy in Elderly Patients

Enrollment closed, study ongoing

Also in this update: Study completion pushed from Jan 2028 to Oct 10, 2028

Harbin Medical UniversityNot applicable NCT07002801 Registry history of NCT07002801 on ClinicalTrials.gov (opens the registry)

Oct 19, 2026
Minor

Liposomal Irinotecan and Capecitabine Plus Bevacizumab as Second-line Therapy in Metastatic Colorectal Cancer

Registry marked status Unknown (sponsor has not verified the record since Jan 2024); last known: Not Yet Recruiting

Harbin Medical UniversityPhase 2 NCT06192680 Registry history of NCT06192680 on ClinicalTrials.gov (opens the registry)

Changed Oct 4, 2026

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1/2		2
Phase 2		15

Not charted: 19 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 19

Heart Disease (6) · Breast Cancer (5) · Colorectal Cancer (4) · Triple-Negative Breast Cancer (4) · Coronary Artery Disease (3) · Cholangiocarcinoma (2) · Esophageal Cancer (2) · Gastric Cancer (2) · Liver Cancer (2) · Lung Cancer (2)

Get alerts when Harbin Medical University's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.

Start monitoring free